Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNano Genomics Inc (BNGO) vs Yum China Holdings Inc (YUMC) Price & Performance

BioNano Genomics IncTrade
Yum China Holdings IncTrade

Price performance (Past 24H)

Key statistics

BioNano Genomics Inc vs Yum China Holdings Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while Yum China Holdings Inc trades at $43 (market cap $14.89B). The key difference: Yum China Holdings Inc is far larger — about 1128× BioNano Genomics Inc's market cap, and Yum China Holdings Inc pays a 2.68% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.

BNGOYUMC
Market Cap
$13.20M$14.89B
Sector
HealthConsumer Cyclical
52-Week High
$4.92$57.95
52-Week Low
$1.09$40.18
Enterprise Value
$15.81M$15.78B
Dividend Yield
2.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNano Genomics Inc

Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.

BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.

Yum China Holdings Inc

YUMC trades at $43.9, up 2.05% today, with strong analyst consensus (14 Buy, 5 Hold, 0 Sell). The stock shows bullish technical signals from moving averages, though RSI levels indicate potential overbought conditions. Recent earnings beats and a P/E of 16.82 suggest reasonable valuation. Key developments include the acquisition of Pizza Hut in mainland China and a $1.5 billion capital return plan for 2026, enhancing shareholder value.

The outlook remains positive given consistent revenue growth, expanding profitability, and strategic acquisitions. Risks include execution challenges in integrating Pizza Hut and macroeconomic pressures in China. With robust cash flows and a clear growth trajectory, YUMC presents a compelling opportunity for long-term investors, though near-term volatility may persist.

Returns comparison

Trailing returns across standard periods

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO

About Yum China Holdings Inc

With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.

Read more on YUMC